Al-Sharif Fadwah M, Abd El-Kader Shehab M, Neamatallah Ziyad A, AlKhateeb Afnan M
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Physical Therapy, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Afr Health Sci. 2020 Jun;20(2):897-902. doi: 10.4314/ahs.v20i2.44.
Activation of immunological and systemic inflammation markers are common in obesity and asthma.
The target of this study was to assess impact of weight reduction on immunological and systemic inflammation markers in obese asthma patients.
Eighty asthmatic patients of both sex; their age and body mass index (BMI) mean were 38.72 ± 7.14 year and 32.65 ± 3.18 Kg/m2 respectively. Exclusion criteria included smokers, infections, vaccinations, cancer, surgery, immune system disorders and medications that may influence immune system function as anti-inflammatory medications, analgesics and anti-depressant. All subjects were randomly enrolled in weight reduction group (group A) or control group (group B).
The main findings in the present study indicated that weight reducing program in group (A) was associated with significant reduction in the mean values of IL6, TNF-α, and IL8 in addition to significant increase in the mean values of CD4 and CD8 cell count . However, findings of group (B) showed no significant changes. Moreover, Comparison between both groups at the end of the study revealed significant differences.
Weight reduction improved immunological and systemic inflammation markers in obese asthma patients.
免疫和全身炎症标志物的激活在肥胖和哮喘中很常见。
本研究的目的是评估体重减轻对肥胖哮喘患者免疫和全身炎症标志物的影响。
80例哮喘患者,男女不限;年龄和体重指数(BMI)平均值分别为38.72±7.14岁和32.65±3.18kg/m²。排除标准包括吸烟者、感染者、接种疫苗者、癌症患者、手术患者、免疫系统疾病患者以及可能影响免疫系统功能的药物,如抗炎药、镇痛药和抗抑郁药。所有受试者随机分为减重组(A组)或对照组(B组)。
本研究的主要发现表明,(A)组的减重计划除了使CD4和CD8细胞计数平均值显著增加外,还使IL6、TNF-α和IL8的平均值显著降低。然而,(B)组的结果显示无显著变化。此外,研究结束时两组之间的比较显示出显著差异。
体重减轻改善了肥胖哮喘患者的免疫和全身炎症标志物。